PUBLISHER: TechNavio | PRODUCT CODE: 1524971
PUBLISHER: TechNavio | PRODUCT CODE: 1524971
The point of care glucose testing market is forecasted to grow by USD 874.6 mn during 2023-2028, accelerating at a CAGR of 4.91% during the forecast period. The report on the point of care glucose testing market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increase in the number of diabetes cases and rising awareness about diabetes, growing geriatric population, and increasing unmet medical needs for the diagnosis and management of diabetes.
Technavio's point of care glucose testing market is segmented as below:
Market Scope | |
---|---|
Base Year | 2024 |
End Year | 2028 |
Series Year | 2024-2028 |
Growth Momentum | Accelerate |
YOY 2024 | 4.41% |
CAGR | 4.91% |
Incremental Value | $874.6mn |
By Type
By Geographical Landscape
This study identifies the focus on introducing low-cost test strips as one of the prime reasons driving the point of care glucose testing market growth during the next few years. Also, rising market adoption of electronic medical records (emrs) and increasing demand for point-of-care testing will lead to sizable demand in the market.
The report on the point of care glucose testing market covers the following areas:
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading point of care glucose testing market vendors that include Abbott Laboratories, ACON Laboratories Inc., Bayer AG, Becton Dickinson and Co., Danaher Corp., EKF Diagnostics Holdings Plc, F. Hoffmann La Roche Ltd., Johnson and Johnson Services Inc., LifeScan IP Holdings LLC, Nipro Corp., Nova Biomedical Corp., PHC Holdings Corp., Prodigy Diabetes Care LL, PTS Diagnostics, Sekisui Medical Co. Ltd., Siemens Healthineers AG, Trinity Biotech Plc, and Trivida Health Inc.. Also, the point of care glucose testing market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Exhibits: